Fresenius Medical Care AG & Co. KGaA (ETR:FME) Receives Average Rating of “Hold” from Brokerages

Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) have received an average rating of “Hold” from the fourteen research firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and six have given a buy recommendation to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is €69.92 ($82.26).

FME has been the topic of a number of recent research reports. Jefferies Financial Group set a €60.00 ($70.59) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “sell” rating in a research note on Tuesday, February 23rd. UBS Group set a €72.00 ($84.71) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Wednesday, February 24th. Berenberg Bank set a €79.50 ($93.53) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Monday, March 1st. The Goldman Sachs Group set a €69.00 ($81.18) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Thursday, March 25th. Finally, Deutsche Bank Aktiengesellschaft set a €65.00 ($76.47) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research report on Thursday, February 4th.

Shares of Fresenius Medical Care AG & Co. KGaA stock traded down €0.32 ($0.38) during trading hours on Thursday, reaching €62.68 ($73.74). The company’s stock had a trading volume of 468,568 shares, compared to its average volume of 704,197. Fresenius Medical Care AG & Co. KGaA has a one year low of €55.18 ($64.92) and a one year high of €79.96 ($94.07). The company has a market capitalization of $18.36 billion and a P/E ratio of 15.91. The stock’s fifty day simple moving average is €60.47 and its two-hundred day simple moving average is €66.62. The company has a debt-to-equity ratio of 100.40, a quick ratio of 0.79 and a current ratio of 1.18.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Read More: Return on Investment (ROI)

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.